Exhibit 107

Calculation of Filing Fee Tables

Form S-1

(Form Type)

Sonnet BioTherapeutics Holdings, Inc.

(Exact Name of Registrant as Specified in its Charter)

Table 1: Newly Registered and Carry Forward Securities

		Security Type		Security Class Title		Fee Calculation or Carry Forward Rule				Amount Registered				Proposed Maximum Offering Price Per Share				Maximum Aggregate Offering Price(1)				Fee Rate				Amount of Registration Fee
Fees to Be Paid		Equity		Common Stock, $0.0001 par value per share⁽²⁾⁽³⁾			457	(o)										$	13,800,000				0.0001102				1,520.76
Fees to Be Paid		Equity		Pre-Funded Warrants⁽³⁾			457	(g)																			(4	)
Fees to Be Paid		Equity		Common Warrants⁽³⁾			457	(g)																			(4	)
Fees to Be Paid		Equity		Underwriter Warrants			457	(g)																			(4	)
Fees to Be Paid		Equity		Common Stock underlying Pre-Funded Warrants⁽²⁾⁽³⁾			457	(o)											(3	)			0.0001102				(3	)
Fees to Be Paid		Equity		Common Stock underlying Common Warrants⁽²⁾			457	(o)										$	13,800,000				0.0001102				1,520.76
Fees to Be Paid		Equity		Common Stock underlying Underwriter Warrants⁽²⁾			457	(o)										$	1,207,500				0.0001102				133.07
				Total Fees Previously Paid																							—
				Total Fee Offsets																						$	—
				Net Fee Due																						$	3,174.59(5	)

(1)	Estimated solely for the purpose of calculating the amount of the registration fee in pursuant to Rule 457(o) under the Securities Act of 1933, as amended (the “Securities Act”).

(2	Pursuant to Rule 416(a) under the Securities Act, this registration statement shall also cover an indeterminate number of shares that may be issued and resold resulting from stock splits, stock dividends or similar transactions.

(3)	The proposed maximum aggregate offering price of the common stock will be reduced on a dollar-for-dollar basis based on the offering price of any pre-funded warrants issued in the offering, and the proposed maximum aggregate offering price of the pre-funded warrants to be issued in the offering will be reduced on a dollar-for-dollar basis based on the offering price of any common stock issued in the offering. Accordingly, the proposed maximum aggregate offering price of the common stock, pre-funded warrants and accompanying common warrants (including the common stock issuable upon exercise of the pre-funded warrants), if any, is $13,800,000 (including the underwriters’ option to purchase additional shares of common stock).

(4)	No separate registration fee is payable pursuant to Rule 457(g) under the Securities Act.

(5)	Previously paid.